Preview Company (Stock code) Date/time Event Presenter
Aquis Exchange - Full Year Results highlights
AQUIS EXCHANGE (AQX) Tue, 29 Mar 2022 07:05 am (UK time) Aquis Exchange - Full Year Results highlights Alasdair Haynes - CEO
Boku - Full Year Results
BOKU INC (BOKU) Tue, 29 Mar 2022 07:00 am (UK time) Boku - Full Year Results Jon Prideaux - CEO
Ariana Resources - Company Update
ARIANA RESOURCES (AAU) Mon, 28 Mar 2022 09:00 am (UK time) Ariana Resources - Company Update Dr Kerim Sener - Managing Director
Open Orphan - £5m RSV human challenge study contract win
OPEN ORPHAN (ORPH) Mon, 28 Mar 2022 09:00 am (UK time) Open Orphan - £5m RSV human challenge study contract win Yamin 'Mo' Khan - Chief Executive Officer
Wickes - Full Year Results
WICKES (WIX) Fri, 25 Mar 2022 09:00 am (UK time) Wickes - Full Year Results David Wood - CEO
Social Housing REIT plc - 2021 Annual Results
SOCIAL HOUSING REIT PLC (SOHO) Fri, 25 Mar 2022 08:30 am (UK time) Social Housing REIT plc - 2021 Annual Results Max Shenkman - Partner, Head of Investment
Poolbeg Pharma - AI Analysis of Human Challenge Data
POOLBEG PHARMA (POLB) Fri, 25 Mar 2022 07:05 am (UK time) Poolbeg Pharma - AI Analysis of Human Challenge Data Jeremy Skillington - Chief Executive Officer
RWS Holdings - Capital Markets Day
RWS HOLDINGS (RWS) Wed, 23 Mar 2022 02:00 pm (UK time) RWS Holdings - Capital Markets Day Andrew Brode - Executive Chairman
ValiRx - Update on proposed sub-license of VAL201
VALIRX PLC (VAL) Wed, 23 Mar 2022 12:56 pm (UK time) ValiRx - Update on proposed sub-license of VAL201 Dr Suzanne Dilly - Chief Executive Officer
Biopharma Credit - Full Year Results
BIOPHARMA CREDIT PLC (BBPCR) Tue, 22 Mar 2022 09:30 am (UK time) Biopharma Credit - Full Year Results Pedro Gonzalez de Cosio - Investment Manager